default author photo

Jingmin Zhao

Government of the People's Republic of China - Department of Pathology and Hepatology

China

SCHOLARLY PAPERS

5

DOWNLOADS

479

TOTAL CITATIONS

4

Scholarly Papers (5)

1.

Detection of Residual HCV RNA in Patients Who Have Achieved Sustained Virological Response Is Associated with Persistent Histological Abnormality

, EBioMedicine, Volume 46, August 2019, Pages 227-235, https://doi.org/10.1016/j.ebiom.2019.07.043
Number of pages: 24 Posted: 02 May 2019
Government of the People's Republic of China - Department of Pathology and Hepatology, Peking University - Peking University Health Science Centre (PUHSC), Jilin University (JLU) - Department of Hematology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Clinical Laboratory, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Advanced Cell Diagnostics, Inc., Jilin University (JLU) - Department of Hepatology, Peking University - People’s Hospital and Government of the People's Republic of China - Department of Pathology and Hepatology
Downloads 133 (547,695)
Citation 1

Abstract:

Loading...

Occult hepatitis C; RNAscope assay; Liver fibrosis; Hepatic pathology

2.

Hepatitis C Virus Elimination is Not Attained in a Certain of Immunocompetent Patients Who Achieved Sustained Viral Response to Direct-Acting Antiviral Agents

Number of pages: 26 Posted: 28 Aug 2018
Government of the People's Republic of China - Department of Pathology and Hepatology, Peking University - Peking University Health Science Centre (PUHSC), Jilin University (JLU) - Department of Hematology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Clinical Laboratory, Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Advanced Cell Diagnostics, Inc., Jilin University (JLU) - Department of Hepatology, Peking University - People’s Hospital and Government of the People's Republic of China - Department of Pathology and Hepatology
Downloads 119 (604,538)

Abstract:

Loading...

Occult Hepatitis C, Direct-Acting Antiviral Agents, Liver Fibrosis, HCV Relapse

3.

Incidence, Predictors and Prognosis of Liver Failure in Patients with Hepatitis E as an Acute Insult

Number of pages: 37 Posted: 28 Nov 2018
Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Beijing 302 Military Hospital of China, Erasmus University Rotterdam (EUR) - Department of Gastroenterology & Hepatology, Erasmus University Rotterdam (EUR) - Department of Gastroenterology & Hepatology and Government of the People's Republic of China - Department of Pathology and Hepatology
Downloads 103 (674,591)

Abstract:

Loading...

hepatitis E; liver failure; predictors; chronic liver disease

4.

Down-Regulation of Cell Membrane Localized NTCP Expression in Proliferating Hepatocytes Prevents Hepatitis B Virus Infection

Number of pages: 50 Posted: 08 Feb 2019
Peking University - Peking University Health Science Centre (PUHSC), Peking University - Peking University Health Science Centre (PUHSC), University of Hamburg - University Medical Center Hamburg-Eppendorf, Chinese Academy of Medical Sciences - Peking Union Medical College, Peking University - Peking University Health Science Centre (PUHSC), Peking University - Peking University Health Science Centre (PUHSC), Peking University - Peking University Health Science Centre (PUHSC), Peking University - Peking University Health Science Centre (PUHSC), Peking University - Peking University Health Science Centre (PUHSC), Beijing 302 Military Hospital of China - Department of Pathology and Hepatology, Tsinghua University - National Institute of Biological Sciences, Peking University - State Key Laboratory of Natural and Biomimetic Drugs, University of Hamburg - Center for Internal Medicine, Government of the People's Republic of China - Department of Pathology and Hepatology and Peking University - State Key Laboratory of Natural and Biomimetic Drugs
Downloads 83 (783,685)
Citation 2

Abstract:

Loading...

sodium taurocholate cotransporting polypeptide (NTCP); hepatocyte proliferation; Hepatitis B virus (HBV) infection; Chronic Hepatitis B (CHB); antiviral therapy; p53; S-phase kinase associated protein 2 (SKP2); cyclin D1

5.

Nonalcoholic Fatty Liver Disease Is Associated with Lower Hepatitis B Viral Load and Antiviral Response in Pediatric Population

Number of pages: 20 Posted: 11 Mar 2019
Peking University - School of Basic Medical Sciences, Government of the People's Republic of China - Department of Pathology and Hepatology, Government of the People's Republic of China - Department of Pathology and Hepatology, Peking University - School of Basic Medical Sciences, Government of the People's Republic of China - Fifth Medical Centre, Peking University - State Key Laboratory of Natural and Biomimetic Drugs and Government of the People's Republic of China - Department of Pathology and Hepatology
Downloads 41 (1,183,237)
Citation 1

Abstract:

Loading...

Nonalcoholic fatty liver disease (NAFLD); Chronic hepatitis B infection (CBI); Lipid metabolism; Antiviral treatment; Pediatric population